Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping

JAMA Neurology

Volumn 70, Issue 2, 2013, Pages 229-234

  Klein, Christopher J ^a   Lennon, Vanda A ^a,b   Aston, Paula A ^a   McKeon, Andrew ^a   O'Toole, Orna ^a   Quek, Amy ^a   Pittock, Sean J ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CONTACTIN ASSOCIATED PROPROTEIN AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LEUCINE RICH GLIOMA INACTIVATED AUTOANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MUSCLE EXCITATION; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REFERENCE VALUE; RETROSPECTIVE STUDY; SEIZURE; SEROLOGY;

EID: 84874028922     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.592     Document Type: Article

References (16)

1. Shillito P, Molenaar PC, Vincent A, et al. Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol. 1995;38(5):714-722
2. Hart IK, Waters C, Vincent A, et al. Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol. 1997;41(2):238-246
3. Liguori R, Vincent A, Clover L, et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain. 2001;124(pt 12):2417-2426
4. Josephs KA, Silber MH, Fealey RD, NippoldtTB, Auger RG, Vernino S. Neurophysiologic studies in Morvan syndrome. J Clin Neurophysiol. 2004;21(6) 440-445.
5. Quek AM, Britton JW, McKeon A, et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy [published online March 26, 2012] Arch Neurol. doi:10.1001/archneurol.2011.2985.
6. Somers KJ, Lennon VA, Rundell JR, et al. Psychiatric manifestations of voltagegated potassium-channel complex autoimmunity. J Neuropsychiatry Clin Neurosci. 2011;23(4):425-433
7. Cornelius JR, PittockSJ, McKeon A, et al. Sleep manifestations of voltage-gated potassium channel complex autoimmunity. Arch Neurol. 2011;68(6):733-738.
8. Flanagan EP, McKeon A, Lennon VA, et al. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc. 2010;85(10) 881-897.
9. Geschwind MD, Tan KM, Lennon VA, et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol. 2008;65(10) 1341-1346.
10. McKeon A, Marnane M, O'connell M, Stack JP, Kelly PJ, Lynch T. Potassium channel antibody associated encephalopathy presenting with a frontotemporal dementia like syndrome. Arch Neurol. 2007;64(10)1528-1530.
11. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in imbic encephalitis previously attributed to potassium channels: a case series Lancet Neurol. 2010;9(8):776-785
12. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channelcomplex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain. 2010;133(9):2734-2748
13. Lancaster E, Huijbers MG, BarV, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol. 2011;69(2):303-311.
14. PittockSJ, KryzerTJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol. 2004;56(5):715-719
15. Apiwattanakul M, McKeon A, PittockSJ, KryzerTJ, Lennon VA. Eliminating falsepositive results in serum tests for neuromuscular autoimmunity. Muscle Nerve. 2010;41(5):702-704.
16. Vincent A, Buckley C, Lang B, Irani S. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology. 2009;72(1):99-author reply 99-100.